DUAKLIR PRESSAIR (aclidinium bromide/formoterol fumarate)
- bronchospasm prevention with COPD
400 mcg-12 mcg/actuation breath activated
- Inhale 1 puff by inhalation route 2 times per day in the morning and evening
Default screening record
- Inhale 1 puff by inhalation route 2 times per day in the morning and evening
- None
Contraindicated
- bromocriptine
- cabergoline
- Cafergot
- Compound 347
- Cycloset
- D.h.e.45
- dihydroergotamine
- enflurane
- ergoloid
- Ergomar
- ergotamine tartrate
- ergotamine-caffeine
- Forane
- isoflurane
- methylergonovine
- Migergot
- Migranal
- Parlodel
- pramlintide
- sevoflurane
- Sojourn
- Symlinpen 120
- Symlinpen 60
- Terrell
- Ultane
Severe
Moderate
- K-tab
- Klor-con
- Klor-con 10
- Klor-con M10
- Klor-con M15
- Klor-con M20
- Medi-lyte
- potassium chloride
- potassium citrate
- potassium Cl-calcium phos-mag
- sodium Cl-potassium chloride
- Thermotabs
- Urocit-k 10
- Urocit-k 15
- Urocit-k 5
- None
Contraindicated
- None
Severe
Moderate
- Angle-closure glaucoma
- Benign prostatic hyperplasia
- Bladder outflow obstruction
- Urinary retention
DUAKLIR PRESSAIR (aclidinium bromide/formoterol fumarate)
- bronchospasm prevention with COPD
- None
- Cough
- Diarrhea
- Dizziness
- Dyspnea
- Flu-like symptoms
- Headache disorder
- Insomnia
- Nausea
- Pharyngitis
- Upper respiratory infection
- Vomiting
- Xerostomia
More Frequent
Severe
Less Severe
- Chest pain
- Chronic heart failure
- Hypertension
- Paradoxical bronchospasm
- Tremor
- Anemia
- Arthralgia
- Back pain
- Cellulitis
- Constipation
- Cough
- Cramps
- Diarrhea
- Dyspnea
- Gastroesophageal reflux disease
- Muscle spasm
- Rhinitis
- Sinusitis
- Toothache
- Urinary tract infection
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Aggravated glaucoma
- Anaphylaxis
- Angina
- Angioedema
- Asthma exacerbation
- Atrial fibrillation
- Cardiac arrhythmia
- Diabetes mellitus
- First degree atrioventricular heart block
- Hyperglycemia
- Hypertension
- Hypokalemia
- Hypotension
- Malaise
- Metabolic acidosis
- Ocular pain
- Paradoxical bronchospasm
- Pharyngeal edema
- Skin rash
- Stomatitis
- Tachycardia
- Urticaria
- Ventricular premature beats
Less Severe
- Arthritis
- Blurred vision
- Edema
- Fatigue
- Hypotension
- Laryngismus
- Mydriasis
- Nausea
- Nervousness
- Palpitations
- Pruritus of skin
- Skin rash
- Symptoms of anxiety
- Tachycardia
- Urinary retention
- Urticaria
- Visual changes
- Voice change
- Xerostomia
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Aclidinium
No safety and efficacy data for pediatrics. Indicated for COPD.
- 1 Day – 18 Years
- No safety and efficacy data for pediatrics. Indicated for COPD.
Aclidinium
- Severity Level:
2
- Additional Notes: Insufficient human data available
Formoterol Fumarate
- Severity Level:
2
- Additional Notes: Insufficient human and animal data available
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Aclidinium
Insufficient human data available
Insuff human data avail;Low plasma levels,amt excret unlikely to be clin sig
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data available |
Formoterol
Insufficient human data available
Insuff human data avail;Low plasma levels,amt excret unlikely to be clin sig
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Unknown | Not known; no or inclusive data | Insuff human data avail;Low plasma levels,amt excret unlikely to be clin sig |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
Aclidinium
Urogenital-Caution with bladder-neck obstruction and in men with benign prostatic hyperplasia. May decrease urinary flow and cause urinary retention. Other-Use caution with narrow angle glaucoma. Gastrointestinal-Anticholinergic effects may worsen constipation in predisposed elderly.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | N | N | N | N | N | N |
BEERS: N HEDIS: N STOPP: Y
No Known Risk
None
- None
Bronchospasm prevention with COPD | |
J44 | Other chronic obstructive pulmonary disease |
J44.8 | Other specified chronic obstructive pulmonary disease |
J44.89 | Other specified chronic obstructive pulmonary disease |
J44.9 | Chronic obstructive pulmonary disease, unspecified |
0-9 | A-Z |
---|---|
J44 | Other chronic obstructive pulmonary disease |
J44.8 | Other specified chronic obstructive pulmonary disease |
J44.89 | Other specified chronic obstructive pulmonary disease |
J44.9 | Chronic obstructive pulmonary disease, unspecified |